Gossamer Bio, Inc.
GOSS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $280 | $249 | $205 |
| - Cash | $9 | $26 | $29 | $46 |
| + Debt | $202 | $203 | $203 | $203 |
| Enterprise Value | – | $456 | $423 | $362 |
| Revenue | $13 | $11 | $10 | $9 |
| % Growth | 15.7% | 16.2% | 5.4% | – |
| Gross Profit | $13 | $11 | $10 | $9 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$45 | -$35 | -$34 | -$32 |
| % Margin | -342% | -307.4% | -339.3% | -337.2% |
| Net Income | -$48 | -$38 | -$37 | -$33 |
| % Margin | -362.7% | -333.1% | -370.5% | -352.2% |
| EPS Diluted | -0.21 | -0.17 | -0.16 | -0.15 |
| % Growth | -23.5% | -6.3% | -6.7% | – |
| Operating Cash Flow | -$36 | -$47 | -$40 | -$35 |
| Capital Expenditures | $0 | -$0 | -$0 | $0 |
| Free Cash Flow | -$36 | -$47 | -$40 | -$35 |